Lingxiang Jiang

419 total citations
22 papers, 281 citations indexed

About

Lingxiang Jiang is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Lingxiang Jiang has authored 22 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Toxicology. Recurrent topics in Lingxiang Jiang's work include Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lingxiang Jiang is often cited by papers focused on Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lingxiang Jiang collaborates with scholars based in United States, China and France. Lingxiang Jiang's co-authors include Xiumei Huang, Zhida Liu, David A. Boothman, Carolien De Cuyper, Yang Wang, Sofie Goormachtig, Tom Beeckman, Aijun Shen, Jian Qiao and Chuanhui Han and has published in prestigious journals such as Nature Communications, Journal of Bone and Joint Surgery and The FASEB Journal.

In The Last Decade

Lingxiang Jiang

18 papers receiving 278 citations

Peers

Lingxiang Jiang
Yue Lin United States
Zhuoqun Li China
Jamal El Saghir Lebanon
Chia-Yang Hung Taiwan
Claire Barbieux France
Yumi Ueda Japan
Yushu Wang China
Bo Zhai China
Shalu Gupta India
Erika Baldoli Italy
Yue Lin United States
Lingxiang Jiang
Citations per year, relative to Lingxiang Jiang Lingxiang Jiang (= 1×) peers Yue Lin

Countries citing papers authored by Lingxiang Jiang

Since Specialization
Citations

This map shows the geographic impact of Lingxiang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiang Jiang more than expected).

Fields of papers citing papers by Lingxiang Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxiang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiang Jiang. The network helps show where Lingxiang Jiang may publish in the future.

Co-authorship network of co-authors of Lingxiang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxiang Jiang. A scholar is included among the top collaborators of Lingxiang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxiang Jiang. Lingxiang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zou, Ming‐Xiang, Pengfei Wu, Haihong Hu, et al.. (2024). Is Type 2 Diabetes Mellitus Associated with Spinal Degenerative Disorders?. Journal of Bone and Joint Surgery. 106(13). 1189–1196. 1 indexed citations
3.
Zhang, Tao‐Lan, Xianpeng Huang, Lingxiang Jiang, et al.. (2024). Single-cell RNA sequencing reveals the MIF/ACKR3 receptor-ligand interaction between neutrophils and nucleus pulposus cells in intervertebral disc degeneration. Translational research. 272. 1–18. 13 indexed citations
4.
Zhang, Tao‐Lan, Chao Xia, Pengfei Wu, et al.. (2024). Hypoxic Upregulation of IER2 Increases Paracrine GMFG Signaling of Endoplasmic Reticulum Stress‐CAF to Promote Chordoma Progression via Targeting ITGB1. Advanced Science. 11(40). e2405421–e2405421. 5 indexed citations
5.
Jiang, Lingxiang, Xiaoguang Li, Tao‐Lan Zhang, et al.. (2024). β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers. OncoImmunology. 13(1). 2363000–2363000. 8 indexed citations
6.
Planchard, David, Pasi A. Jänne, Ying Cheng, et al.. (2023). 512MO FLAURA2: Safety and CNS outcomes of first-line (1L) osimertinib (osi) ± chemotherapy (CTx) in EGFRm advanced NSCLC. Annals of Oncology. 34. S1668–S1668.
7.
Hu, Haihong, Ting Yan, Hongxia Zhu, et al.. (2023). A novel immune checkpoint-related signature for prognosis and immune analysis in breast cancer. Clinical and Experimental Medicine. 23(8). 5139–5159.
8.
Hu, Haihong, Ming‐Xiang Zou, Hongjuan Hu, et al.. (2023). A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel. npj Precision Oncology. 7(1). 130–130. 7 indexed citations
9.
Jiang, Lingxiang, Matthew W. Boudreau, Jiangwei Wang, et al.. (2023). Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill NQO1 -Positive Pancreatic Cancer Cells. Antioxidants and Redox Signaling. 41(1-3). 74–92. 4 indexed citations
10.
Zhang, Tao‐Lan, Hongxia Zhu, Hongjuan Hu, et al.. (2023). Cardiovascular-specific mortality and risk factors in colorectal Cancer patients: A cohort study based on registry data of over 500,000 individuals in the US. Preventive Medicine. 179. 107796–107796. 5 indexed citations
11.
12.
Zhang, Tao‐Lan, Chao Xia, Haihong Hu, et al.. (2023). Integrating single-cell and spatial transcriptomics reveals endoplasmic reticulum stress-related CAF subpopulations associated with chordoma progression. Neuro-Oncology. 26(2). 295–308. 21 indexed citations
13.
Zahid, Kashif Rafiq, et al.. (2022). Neutrophils: Musketeers against immunotherapy. Frontiers in Oncology. 12. 975981–975981. 18 indexed citations
14.
Zhao, Wenxiu, Lingxiang Jiang, Ting Fang, et al.. (2021). β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Frontiers in Oncology. 11. 747282–747282. 21 indexed citations
15.
Su, Xiaolin, Jiangwei Wang, Lingxiang Jiang, & Xiumei Huang. (2021). Synergistic Lethality between Beta‐lapachone and Proliferating Cell Nuclear Antigen (PCNA) Inhibitor in NQO1‐positive Cancer Cells. The FASEB Journal. 35(S1). 1 indexed citations
16.
Su, Xiaolin, Jiangwei Wang, Lingxiang Jiang, et al.. (2021). PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage. Cancer Letters. 519. 304–314. 14 indexed citations
17.
Jiang, Lingxiang, et al.. (2020). Sex difference in the association of APOE4 with cerebral glucose metabolism in older adults reporting significant memory concern. Neuroscience Letters. 722. 134824–134824. 12 indexed citations
18.
Li, Xiaoguang, Zhida Liu, Anli Zhang, et al.. (2019). NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nature Communications. 10(1). 3251–3251. 74 indexed citations
19.
Jiang, Lingxiang, Belén Márquez‐García, Carolien De Cuyper, et al.. (2015). Strigolactones spatially influence lateral root development through the cytokinin signaling network. Journal of Experimental Botany. 67(1). 379–389. 62 indexed citations
20.
Fang, Ming, et al.. (2013). Alterations of angiopoietin‐related growth factor (Angptl6) during pregnancy and in pre‐eclampsia. Journal of obstetrics and gynaecology research. 39(6). 1137–1141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yue Lin Breakdown of academic impact, for papers by Zhuoqun Li Breakdown of academic impact, for papers by Jamal El Saghir Breakdown of academic impact, for papers by Chia-Yang Hung Breakdown of academic impact, for papers by Claire Barbieux Breakdown of academic impact, for papers by Yumi Ueda Breakdown of academic impact, for papers by Yushu Wang Breakdown of academic impact, for papers by Bo Zhai Breakdown of academic impact, for papers by Shalu Gupta Breakdown of academic impact, for papers by Erika Baldoli
Rankless by CCL
2026